Chen Qian Kun
Chen Qian Kun — Chief Physician — Thoracic Surgery — Shanghai Pulmonary Hospital
Specialties
The application of single-port thoracoscopic minimally invasive surgery includes the early diagnosis and surgical treatment of various diseases in general thoracic surgery, such as lung cancer, pneumothorax with pulmonary bullae, tracheal tumors, mediastinal tumors, bronchiectasis, chest wall tumors, tuberculosis, and empyema. It is proficient in the diagnosis and minimally invasive treatment of early lung cancer, such as intrapulmonary small nodules and ground-glass nodules; lung transplantation for end-stage lung disease; minimally invasive thoracoscopic surgery for locally advanced lung cancer, including tracheobronchial reconstruction and sleeve resection, pulmonary artery reconstruction and sleeve resection, complex pulmonary segmental, combined segmental, and subsegmental resections. Da Vinci robotic thoracic surgery.
Education
Graduated from Fudan University School of Medicine (Shanghai Medical University Seven-Year Clinical Program), PhD in Surgery
Professional Experience
Chen Qiankun, master's supervisor, studied abroad in the Department of Thoracic Tumor Surgery at Okayama University School of Medicine in Japan from April 2006 to March 2007, funded by the Sasakawa Medical Scholarship from the Ministry of Health, and in 2009, conducted visiting research in the Department of Thoracic Surgery at Barnes-Jewish Hospital, Washington University School of Medicine, USA. He participates in over 10 domestic and international major academic conferences every year, broadcasting live thoracoscopic surgeries online. He performs over 1,500 surgeries annually. In 2015, he received the 15th Shanghai Health System Outstanding Young Talent Highest Honor Award - Silver Snake Award. In 2018, he won the Second Prize of the Chinese Medical Science and Technology Award for key technologies and clinical promotion in minimally invasive pulmonary surgery. He has received the 'National Annual Good Doctor' award for 10 consecutive years. In 2021, he won the First Prize of Shanghai Scientific and Technological Progress for the development, clinical application, and promotion of key minimally invasive technologies in pulmonary surgery. He has led and participated in multiple projects of the Municipal Health Bureau and Municipal Science and Technology Commission, and has applied for four national new utility model patents.